Australian currency cash
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Tungsten Mining (ASX:TGN) saw investors shaken out of the tree on Monday morning despite a strong start to Week 7 as the company clearly surprised some with its disclosure of the completion of a $53M placement at a discount.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

That the sell-off is relatively subdued one likely owes to the ongoing market enthusiasm for metals (especially defence metals like tungsten) and the fact a $53M injection ought to keep the company going for a foreseeable while.

Also, the company’s up +150 over the last year.

TGN wrote on Monday it’s now “in a strong financial position to accelerate project activities … as the Company advances through the next phases of project evaluation.”

Among those activities: a pre-feas study for its Mt Mulgine project due in Q3 of CY26 and an evaluation study for its Watershed project in Q2.

Still, 278.9M shares were issued, diluting the existing pool. That’s always going to have detractors. That said, the company’s up +150% over the last year.

Most worth noting is that clear conviction remains common among its base: down over -5% on Monday to 25cps, that’s still strongly above the placement price, which was at 19cps.

TGN last traded at 25cps.

Join the discussion: See what HotCopper users are saying about TGN and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

tgn by the numbers
More From The Market Online

KGL Resources jumps 25% on US$300M funding deal

KGL Resources has entered into a US$300 million PMPA to help fund construction and development of…
London

With osteo Phase 3 trial at 50% recruitment, Paradigm Bio inks partnership with University of London

Paradigm Biopharma (ASX:PAR) has this week hit two big items out the park: first of all, hitting 50% recruitment

Terra hits multiple intersections at Southwest SW6 prospect; assays now due in next ~12 weeks

Terra Metals has hit multiple intersections of massive sulphides in drilling at the Southwest SW6 prospect…
Easter bunny in a business suit analyzing stock charts, symbolizing market strategy

ASX closed for Easter long weekend. Enjoy your chocolates and the holiday break!

Yes, yes, I know you’re itching to do some serious Australian market trading today, but everyone — especially our much-loved HotCopper forum users